The Living Guidelines: STEMI Anticoagulants for STEMI patients who do not go reperfusion therapy Suggest Revisions to the CLASS IIa Guidelines

Any recommendations found on these pages are for education use only. WikiDoc is not a substitute for a licensed healthcare provider. Please see the disclaimers page for important information regarding limitations of the information found here. In suggesting edits to the guidelines, WikiDoc suggests that the following classification scheme be used. Read more about the classification scheme used by the ACC / AHA Guidelines Committee here.

Instructions on How to Edit the Guidelines:
 * Log in
 * Click on "Edit"
 * Type in changes to guidelines
 * Click "Save page" at the bottom of the page

Class IIa Guidelines

 * 1) It is reasonable for patients with STEMI who do not undergo reperfusion therapy to be treated with anticoagulant therapy (non-UFH regimen) for the duration of the index hospitalization, up to 8 days. (Class II a, Level of Evidence: B)
 * Convenient strategies that can be used include those with LMWH (Class II a, Level of Evidence: C) or fondaparinux (Class II a, Level of Evidence: B) using the same dosing regimens as for patients who receive fibrinolytic therapy.